π dailymail.co.uk
Moderna's mRNA cancer vaccine slashes risk of tumors returning in advanced melanoma patients | Daily Mail Online
Pharma giants Merck and Moderna, which are co-developing the shot, said the results are
β https://www.dailymail.com/health/article-11533153/New-paradigm-moment-mRNA-cancer-vaccine-slashes-risk-tumor-relapse-death.html